Special Edition: PharmD Appreciation: “PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based solutions to the everyday challenges. This series, published during American Pharmacists Month, celebrates our pharmacist CV Team members in an educational series with a specific Pharmacist focus. In this episode, Andrea Price, MS, AACC hosts Tomasz Jurga, PharmD, BCPS, BCACP, BCCP, HF-Cert, AACC; Lydia Tran, PharmD, BCPS and Bruce Warden, PharmD, BCPS, FNLA, FASPC to discuss the role of the pharmacists of the care team for lipid management.   

 Subscribe to CardiaCast  

Special Edition: PharmD Appreciation: “PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based solutions to the everyday challenges. This series, published during American Pharmacists Month, celebrates our pharmacist CV Team members in an educational series with a specific Pharmacist focus. In this episode, Andrea Price, MS, AACC hosts Lydia Tran, PharmD, BCPS and Sushma Dey, PharmD, BCACP to discuss the role of the pharmacists on the care team for hypertension management.   

Subscribe to CardiaCast  

PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. This series, published during Peripheral Artery Disease (PAD) Awareness Month, is in collaboration with the ACC’s Vascular Disease Section. In this episode, Andrea Price, MS, AACC hosts Hussein Abu Daya MD, FACC, Brian Rose, PA-C, MPH, AACC and Bailey Estes MSN, AGNP-C, to begin the PAD series with an introductory overview.  

“Courtside with the Chair” is a new series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this “Part 2” episode, Dr. Jonathan Kim continues the conversation with Drs. Michael Ackerman, Rachel Lampert, and Matthew Martinez of the “how to” and approach to shared decision-making in the context of sports participation for athletes with heart disease. 

Suggested Materials: (You can include formal references external to ACC.org here. Please list numerically as formal citations. Example: Cannon JA, Moffitt P, Perez-Moreno AC, et al. Cognitive impairment and heart failure: systematic review and meta-analysis. J Card Fail 2017;23:464-75).     

 Subscribe to CardiaCast | Claim CME Credit 

In this episode, Drs. Erin Michos and Steven Nissen discuss newly emerging therapies for elevated Lp(a) management and forthcoming developments in research. Drs. Michos and Nissen highlight the key differences between therapies in late trial stages and discuss upcoming cardiovascular outcome trials. 

This CardiaCast episode is part of an ACC course titled Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap. Educational grant support is provided by Novartis. To visit the Online Course page for the Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap Grant, click here! 

 Suggested Materials:  

1. Reyes-Soffer G, Yeang C, Michos ED, Boatwright W, Ballantyne CM. High lipoprotein(a): actionable strategies for risk assessment and mitigation. Am J Prev Cardiol. 2024;18:100651.  

1. Tsimikas S, Fazio S, Ferdinand KC, et al. NHLBI Working Group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis. J Am Coll Cardiol 2018;71:177-92.   

1. Reyes-Soffer G, Ginsberg HN, Berglund L, et al; on behalf of the American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; and Council on Peripheral Vascular Disease. Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association. ArteriosclerThromband Vasc Biol 2022;42:e48-e60.   

1. Koschinsky ML, Bajaj A, Boffa MB, et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol 2024;18:e308-e319.  

Subscribe to CardiaCast | More information on Elevating Lp(a) HERE 

“Courtside with the Chair” is a new series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this episode, Dr. Jonathan Kim is joined by Drs. Michael Ackerman, Rachel Lampert, and Matthew Martinez to discuss the “why” and “how to” related to shared decision-making in the context of sports participation for athletes with heart disease. 

 Subscribe to CardiaCast | Claim CME Credit 

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. This episode is an update to the March 2024 PulseCheck: Shared Decision Making podcast in which host Andrea Price MS, AACC brings together Liz Perpetua ARNP, ACNP-BC, DNP, FACC, Martha Gulati MD, MS, FACC, and Bailey Estes MSN, AGNP-C, to explore best practices related to structural heart disease. Dr. Perpetua, the chair and lead author of JACC Advances Expert Panel Perspective: Shared Decision-Making in Multidisciplinary Team-Based Cardiovascular Care, offers insights from the July 2024 publication. 

Subscribe on iTunes | Subscribe on Google Play |  

In this episode, Drs. Erin Michos and Gissette Reyes-Soffer discuss how clinicians can manage elevated Lp(a) by treating all modifiable factors in patients. The global risk assessment of patients and what can be done now to navigate and mitigate risk is also addressed. 

 This CardiaCast episode is part of an ACC course titled Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap. Educational grant support is provided by Novartis. To visit the Online Course page for the Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap Grant, click here! 

 Suggested Materials:  

1. Reyes-Soffer G, Yeang C, Michos ED, Boatwright W, Ballantyne CM. High lipoprotein(a): actionable strategies for risk assessment and mitigation. Am J Prev Cardiol 2024;18:100651.   

1. Tsimikas S, Fazio S, Ferdinand KC, Ginsberg HN, Koschinsky ML, Marcovina SM, et al. NHLBI Working Group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis. J Am Coll Cardiol 2018;71:177-92.   

1. Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, et al; on behalf of the American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; and Council on Peripheral Vascular Disease. Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol 2022;42:e48-e60.  

1. Koschinsky ML, Bajaj A, Boffa MB, et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol 2024;Mar 29:[ePub ahead of print].  

Subscribe to CardiaCast | More information on Elevating Lp(a) HERE 

In this episode, Drs. Erin Michos and Christie Ballantyne examine the importance of testing and identifying lipoprotein(a) ( Lp[a]) levels in patients, research highlighting trends in populations at risk, and the genetic factors involved in assessment. The significance associated with various levels of Lp(a) in measurement and how testing plays a role in management is also discussed. 

This CardiaCast episode is part of an ACC course titled Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap. Educational grant support is provided by Novartis. To visit the Online Course page for the Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap Grant, click here! 

In this episode, Drs. Maya Guglin, Nikhil Narang, Dustin Hillerson, Anju Bhardwaj, and Megan Pelter will delve into recently published randomized controlled clinical trials on venoarterial extracorporeal membrane oxygenation (VA-ECMO). They will cover trials on cardiogenic shock, including the ECMO-CS multicenter randomized trial, and discuss findings from the EVOLVE-ECMO trial on left ventricular venting. 

In this episode of CardiaCast, world-renowned hypertrophic cardiomyopathy (HCM) expert Dr. Matthew Martinez will review changes occurring in the field of HCM and explore best practice recommendations from the newly issued guideline, 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. 

This podcast is part of the 2024 Update to the AHA/ACC HCM Guidelines: Expert Interpretation for Application to Practice grant initiative presented by ACCF and Med-IQ. 

“Heart Vision” is a new CardiaCast podcast series stemming from the ACC Cardiovascular Imaging Section Leadership Council. This podcast series will tackle topics on emerging multimodality imaging data, trends, practice patterns, disease status and advocacy effort. 

In this episode, Drs. Purvi Parwani and Christopher Kramer will discuss the main imaging highlights from 2024 Guideline for the Management of Hypertrophic Cardiomyopathy.  

In this installment of Atrial Fibrillation (AFib) and Antiarrhythmic Drugs (AADs) series, Dr. Suneet Mittal interviews Dr. Jeff Healey about evidence supporting the guidelines and how they compare to previous guidelines. Listen as Dr. Healey analyzes the utilization of AADs based on the 2023 guidelines. 

This podcast is part of Early Onset of Atrial Fibrillation & the Contemporary Use of Antiarrhythmic Drugs grant initiative. 

Educational grant support is provided by Sanofi. Click here for more: https://learn.acc.org/Page/LearnAntiarrhythmicDrugsforAF  

Subscribe to CardiaCast | Claim CME Credit 

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. This special series published during Mental Health Awareness Month is sponsored by ACC’s Cardiovascular Psychology Workgroup. In this episode, host Andrea Price MS, AACC talks with Yale University psychologists Kim G. Smolderen, PhD, FACC and Lynelle Schneeberg, PsyD about basic sleep hygiene and the link between sleep and cardiovascular risk factors.  

 Related References:  

1. Hall MH, Brindle RC, Buysse DJ. Sleep and cardiovascular disease: emerging opportunities for psychology. Am Psychol 2018;73:994-1006. 

1. Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2021;144:e56-e67. 

 Subscribe to CardiaCast  

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. This special series published during Mental Health Awareness Month is sponsored by ACC’s Cardiovascular Psychology Workgroup.  In this episode, Andrea Price, MS, AACC hosts Jill Steiner, MD, MS, FACC, and Rosy Thachil, MD, FACC for a discussion on the importance of social support and its role in promoting good mental health, especially among people with a chronic illness like heart disease. Connections between social support and stress, health behaviors, and medical decision making will be highlighted.  

 Related References:  

1. Liang YY, Chen L, Feng H, et al. Association of social isolation and loneliness with incident heart failure in a population-based cohort study. JACC: Heart Fail 2023;11:334-44. 

1. Freak-Poli R, Ryan J, Neumann JT, et al. Social isolation, social support and loneliness as predictors of cardiovascular disease incidence and mortality. BMC Geriatr 2021;21:711.   

 Subscribe to CardiaCast  

 “PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. This special series published during Mental Health Awareness Month is sponsored by ACC’s Cardiovascular Psychology Workgroup.  In this episode, host Andrea Price MS, AACC brings together Jamie Jackson, PhD, and David Harrison, MD, to discuss screening for psychological distress (e.g., PHQ-4) and when to refer patients for further evaluation. The importance of identifying psychological distress in cardiovascular medicine is highlighted.  

 Subscribe to CardiaCast  

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. This special series published during Mental Health Awareness Month is sponsored by ACC’s Cardiovascular Psychology Workgroup. In this episode, host Andrea Price MS, AACC brings together Kim. Smolderen, PhD, FACC and Zena Samaan, MBChB, MSc, DMMD, PhD to examine trauma-informed care and the spectrum of cardiovascular conditions and health through the lens of psychology.  

Dive into the Heart of ACC.24's Heart Failure and Transplant Highlights! In this podcast, Drs. Maya Guglin, Shelley Hall, Onyedika Ilonze, and Kazuhiko Kido dissect the most captivating advancements and groundbreaking revelations from the ACC.24 sessions in heart failure and transplant, including trials RELIEVE-HF, REDUCE-AMI, and DanGer Shock. Join us as we navigate through the latest research, innovative therapies, and paradigm-shifting insights that promise to reshape the landscape of cardiovascular medicine. Whether you're a seasoned clinician, researcher, or enthusiast, prepare to be inspired and informed as we unravel the future of cardiac care together! 

Educational grant support for ACC.24’s Learning Pathways and this podcast provided by Merck Sharp & Dohme Corp. 

In this episode, Drs. Erin Michos and Leslie Cho discuss the research presented at ACC.24 related to statin intolerance and bempedoic acid. Dr. Cho’s research publication “Characteristics and Outcomes for Statin Intolerant Women Receiving Bempedoic Acid in The Clear Outcomes Trial” is discussed, as well as lipid management for women, Hispanic, Latinx, and obese patients in the CLEAR Outcomes Trial. 

This podcast is part of Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape grant initiative.  

  Educational grant support is provided by Esperion.  

 Related References:  

• Cho L, Plutzky J, Brennan D, et al. Characteristics and outcomes for statin-intolerant women receiving bempedoic acid in the CLEAR OUTCOMES trial. J Am Coll Cardiol 2024;83:1751.  

• Rodriguez F, Brennan D, Lei L, Nissen SE, Powell H, Plutzky J. Characteristics and outcomes for statin-intolerant Hispanic/Lantinx women receiving bempedoic acid: results from a CLEAR OUTCOMES pre-specified subanalysis. J Am Coll Cardiol 2024;83:1811.  

• Bays HE, Bloedon L, Brennan D, et al. Bempedoic acid and cardiovascular disease outcomes in patients with obesity: a CLEAR OUTCOMES subset analysis. J Am Coll Cardiol 2024;83:1967.  

• Nissen SE, Menon V, Nicholls SJ, et al. Bempedoic acid for primary prevention of cardiovascular events in statin-intolerant patients. JAMA 2023;330:131-140. 

 Subscribe to CardiaCast | More Information on Bempedoic Acid HERE  

“Heart Vision” is a new CardiaCast podcast series stemming from the ACC Cardiovascular Imaging Section Leadership Council. This podcast series will tackle topics on emerging multimodality imaging data, trends, practice patterns, disease status and advocacy effort.  

In this episode, Drs. Jamie Bourque and Mathew Parker discuss the multimodality assessment of suspected or known cardiovascular infection, including:  

• the application, strength, and limitations of echocardiography 

• when additional advanced imaging can be helpful for patient management 

• assessment of extracardiac manifestations of cardiovascular infection 

• the role of radionuclide imaging in native valve endocarditis 

 Related References:  

Bourque J, Birgersdotter-Green U, Bravo P, et al. 18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC imaging indications (ASNC I2) series expert consensus recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS. J Am Coll Cardiol Img 2024;Mar 11:[ePub ahead of print].  

“Courtside with the Chair” is a new series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In Part 2, Dr. Jonathan Kim continues the conversation with Drs. Maron, Harmon, and Baggish discussing the principles of shared decision-making in the context of sports participation for athletes with heart disease and ‘the why’ to do it.  

Subscribe to CardiaCast | Claim CME Credit 

“Courtside with the Chair” is a new series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this episode, Dr. Jonathan Kim is joined by Drs. Marty Maron, Kim Harmon, and Aaron Baggish to discuss the principles of shared decision-making in the context of sports participation for athletes with heart disease and ‘the why’ to do it.  

Subscribe to CardiaCast | Claim CME Credit 

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In this panel discussion, host Andrea Price MS, AACC brings together Martina Speight FNP-BC, MS(Martina), Jane Linderbaum ARNP, CNP, FACC and Bailey Estes MSN, AGNP-C to explore best practices related to structural heart disease. In this episode, the focus is on Advanced Practice Provider Updates. 

Subscribe on iTunes 

Special Edition: PharmD Appreciation: “PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members are new, or new to cardiology, offering practical team-based solutions to the everyday challenges. This series, published during American Pharmacists Month, celebrates our pharmacist CV Team members in an educational series with a specific Pharmacist focus. In this episode, Andrea Price, MS, AACC hosts Anastasia Armbruster, PharmD, FACC, BCCP and Megan Labreck, PharmD, BCPS, CACP to discuss the most recent atrial fibrillation (Afib) guidelines and what the documents mean to a pharmacist working on a cardiac arrhythmia care team.  

Subscribe to CardiaCast  

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In this panel discussion, host Andrea Price MS, AACC brings together Holly Dalton, MSN, Joan Michaels, RN, AACC,  and Bailey Estes MSN, AGNP-C, to explore best practices related to structural heart disease. In this episode, the focus is on quality in structural heart.  

Subscribe on iTunes 

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In this panel discussion, host Andrea Price MS, AACC brings together Liz Perpetua ARNP, ACNP-BC, DNP, FACC, Martha Gulati MD, MS, FACC, and Bailey Estes MSN, AGNP-C, to explore best practices related to structural heart disease. In this episode, the focus is on shared decision making. 

Subscribe on iTunes | 

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In this panel discussion, host Andrea Price MS, AACC brings together Tricia Keegan, NP, DNP, FACC, Disty Pearson, PA-C, AACC, and Bailey Estes MSN, AGNP-C, to explore best practices related to structural heart disease. In this episode, the focus is on congenital heart disease. 

 Subscribe on iTunes | Subscribe on Google Play |  

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In this panel discussion, host Andrea Price MS, AACC brings together Jasmina Katinic ARNP, AACC(Jasmina),  Nicole Jones ACNS-BC, CCNS, CHFN, AACC, and Bailey Estes MSN, AGNP-C, to explore best practices related to structural heart disease. In this episode, the focus is on left atrial appendage closure. 

Subscribe on iTunes | Subscribe on Google Play |  

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In this panel discussion, host Andrea Price MS, AACC brings together Marcus Burns, DNP, Kristen deAlmeida, PharmD, and Bailey Estes MSN, AGNP-C, to explore best practices related to structural heart disease. In this episode, the focus is on tricuspid valve disease.  

Subscribe on iTunes | 

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Nicole Dellise, NP, and Kristen deAlmeida, PharmD to explore best practices related to structural heart disease. In this episode, the focus is on mitral valve disease.  

 Subscribe on iTunes | Subscribe on Google Play |  

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price, MS, AACC brings together Marian Hawkey, RN and Misty Theriot, BSN to explore best practices related to structural heart disease. In this episode, the focus is on aortic valve stenosis.  

 Subscribe on iTunes | Subscribe on Google Play |  

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In this panel discussion, host Andrea Price MS, AACC brings together Gigi Wyman, DNP, RNCS FACC and Wayne Batchelor, MD, FACC and Bailey Estes MSN, AGNP-C, to explore best practices related to structural heart disease. In this episode, the focus is on the Heart Team Approach.  

 Subscribe on iTunes | Subscribe on Google Play |  

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Kim Guibone, DNP, ACNP-BC, FACC, Susan Schnell, ACNP and Bailey Estes MSN, AGNP-C, to explore best practices related to structural heart disease. In this episode, the focus is on an introduction to structural heart disease.  

Subscribe on iTunes | Subscribe on Google Play |  

Drs. Rosy Thachil and Shashank Sinha continue their series, “Conversations with Critical Care Cardiologists”, sponsored by ACC’s Critical Care Cardiology (CCC) Section. In this episode, Drs. Thachil and Sinha talk with Drs. David Morrow and Elliott Miller regarding their December 2023 Journal of American College of Cardiology publication, a multinational perspective on “Research Priorities in Critical Care Cardiology”. Drs. Morrow and Miller explore the challenges and opportunities in generating high-quality evidence for treating complex, critically ill cardiac patients. With limited clinical trials and guidelines specific to CCC, they examine the variation in cardiovascular intensive care unit practices and identify key areas for CCC research, challenges in the field, and important strategies to enhance future progress.

In this episode of CardiaCast, hypertrophic cardiomyopathy (HCM) expert Dr. Matthew Martinez will discuss with Dr. Michelle Kittleson recommendations for early diagnosis in the 2024 HCM guideline and review the latest clinical and real-world trial data for new (mavacamten) and emerging (aficamten) cardiac myosin inhibitors.  

This CardiaCast is part of an educational series, “2024 Update to the AHA/ACC HCM Guideline: Expert Interpretation for Application to Practice,” which includes a total of three ACC CardiaCasts and an accredited #MedX. The series is produced by the American College of Cardiology Foundation and Med-IQ and supported by an educational grant from Bristol Myers Squibb. Exploring HCM Diagnosis and Treatment Options: The New Frontier of Cardiac Myosin Inhibitors (acc.org) 

 Suggested Materials:   

1. Olivotto I, Oreziak A, Barriales-Villa R, et al; EXPLORER-HCM study investigators. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2020;396:759-69. Erratum in: Lancet 2020;396:758.  

1. Desai MY, Owens A, Wolski K, et al. Mavacamten in patients with hypertrophic cardiomyopathy referred for septal reduction: week 56 results from the VALOR-HCM randomized clinical trial. JAMA Cardiol 2023;8:968-77.  

1. Maron MS, Masri A, Nassif ME, et al; SEQUOIA-HCM Investigators. Aficamten for symptomatic obstructive hypertrophic cardiomyopathy. N Engl J Med 2024;390:1849-61.  

“Heart Vision” is a new CardiaCast podcast series stemming from the ACC Cardiovascular Imaging Section Leadership Council. This podcast series will tackle topics on emerging multimodality imaging data, trends, practice patterns, disease status and advocacy effort.  

 In this episode, Drs. Purvi Parwani and João L. Cavalcante will discuss Valvular Heart Disease: Multimodality imaging evaluation, the future of advanced imaging, future imaging markers in development for patients with valvular heart disease.  

Suggested Materials:  

Myerson SG. CMR in evaluating valvular heart disease: diagnosis, severity, and outcomes. J Am Coll Cardiol Img 2021;14:2020-32. 

Drs. Rosy Thachil and Shashank Sinha continue their series, “Conversations with Critical Care Cardiologists”, sponsored by ACC’s Critical Care Cardiology (CCC) Section. In this episode, Drs. Thachil and Sinha interview the co-directors and co-founders of the New York University (NYU) Langone Critical Care Cardiology Symposium, Drs. Carlos Alviar and James Horowitz.  

 The NYU Critical Care Cardiology Symposium is the first of its kind in North America to provide a comprehensive state-of-the-art approach to the evaluation and management of patients with acute cardiovascular conditions in the contemporary cardiac intensive care unit (CICU). The CICU has undoubtedly evolved in recent years with respect to complexity, acuity, and severity of illness. The NYU Critical Care Cardiology Symposium provides a dedicated educational space pertaining to the care of these critically ill cardiac patients. More information about the conference can be found here (save the date for October 25-26, 2024!).   

Please also don’t forget to join ACC’s Critical Care Cardiology (CCC) Section at ACC.org! 

“Heart Vision” is a new CardiaCast podcast series stemming from the ACC Cardiovascular (CV) Imaging Section Leadership Council. This podcast series will tackle topics on emerging multimodality imaging data, trends, practice patterns, disease status and advocacy effort.  

 In this first “Heart Vision” episode, Drs. Purvi Parwani and Jamieson Bourque are joined by Dr. Ron Blankstein, current Chair of Cardiovascular Imaging Section Leadership Council. Together they discuss present challenges and opportunities ahead in the world of multimodality imaging and the role of the ACC CV Imaging Council in meeting those challenges. 

“Courtside with the Chair” is a new series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In Part 2 of this episode, Dr. Jonathan Kim is joined by Drs. Sawalla Guseh, Rachel Lampert, and Dermot Phelan who discuss pitfalls to consider in various cardiac screening strategies employed for athletes, including history and physical, electrocardiogram and other imaging modalities, and approaches to mitigate these issues for health care professionals involved in athlete physicals. 

 Subscribe to CardiaCast  

In this episode, Drs. Erin Michos and Leslie Cho discuss the representation of women in clinical trials and the diversity of the CLEAR Outcomes Trial. 

This podcast is part of Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape grant initiative. 

 Educational grant support is provided by Esperion. 

 Suggested Materials: 

1. Nissen SE, Menon V, Nicholls SJ, et al. Bempedoic acid for primary prevention of cardiovascular events in statin-intolerant patients. JAMA 2023;330:131-140.  

  Subscribe to CardiaCast | More Information on Bempedoic Acid HERE 

“Courtside with the Chair” is a new series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this episode, Dr. Jonathan Kim is joined by Drs. Sawalla Guseh, Rachel Lampert, and Dermot Phelan who discuss pitfalls to consider in various cardiac screening strategies employed for athletes, including history and physical, electrocardiogram and other imaging modalities, and approaches to mitigate these issues for health care professionals involved in athlete physicals. 

 Subscribe to CardiaCast  

Do you ever wonder how care delivery for the sickest patients with heart disease in the cardiac intensive care unit (CICU) has changed in the last few decades? Who belongs, both patients and providers, in the CICU? Advanced practice providers (APPs), in particular, have an increasingly important role and responsibility in supporting these complex, interdisciplinary teams.    

 Welcome to this episode, “Invaluable and Indispensable: Integrating Advanced Practice Providers in the Cardiac Intensive Care Unit,” the latest in our ongoing ACC CardiaCast series entitled “Conversations with Critical Care Cardiologists.” We are truly honored to welcome our esteemed guests from Duke University, Drs. Callie Tennyson and Jason Katz, to discuss their timely and topical upcoming publication in the Journal of American College of Cardiology entitled “Role of Advanced Practice Providers in the Cardiac Intensive Care Unit Team.” 

In this episode, Drs. Pamela Mason and Ijeoma Ekeruo discuss the risk of stroke with atrial fibrillation (AF) and method patients can use to reduce this risk. In particular, Drs. Mason and Ekeruo discuss left atrial appendage occlusion procedures that can prevent strokes for patients with AF.  

 Subscribe to CardiaCast | Claim CME Credit 

Our understanding of menopausal hormone therapy (MHT) and cardiovascular (CV) risk has evolved over the last two decades, with data that can inform decision making. The topic, at the intersection of cardiology and women’s health, is an important issue for our female patients and health care providers. Despite this, managing CV risk, and the risk associated with MHT in women, is not emphasized in cardiology training. In this episode, Drs. Abramson, Ahmed, Kalenga, and McLaughlin address these knowledge gaps and discuss new research on the relationship between MHT and hypertension. Additionally, the broader issue of addressing CV risk in post-menopausal women requiring or requesting MHT and counseling and managing women on hormone therapy from the cardiologist’s perspective are also examined. 

 Subscribe to CardiaCast  

“Women are Not Little Men” is a new podcast series within CardiaCast designed for cardiovascular health providers to increase awareness of sex-based differences in cardiovascular disease (CVD) and to improve the clinical care of women with CVD. “Women are Not Little Men” is hosted by Drs. Emily Lau and Niti Aggarwal, nationally renowned experts in women’s CVD and members of the American College of Cardiology CVD in Women Committee. In this episode, Drs. Marcelo DiCarli and Odayme Quesada discuss the diagnosis and management of the full spectrum of ischemic heart disease in women through the lens of multimodality imaging. In particular they highlight the pivotal role of stress cardiac magnetic resonance imaging and quantitative positron emission tomography perfusion imaging to diagnose microvascular disease.  

Suggested Materials:  

 Samuels BA, Shah SM, Widmer RJ, et al. Comprehensive management of ANOCA, part 1—definition, patient population, and diagnosis: JACC State-of-the-Art Review. J Am Coll Cardiol 2023;82:1245–63. 

 Smilowitz N, Prasad M, Widmer RJ, et al. Comprehensive management of ANOCA, part 2—program development, treatment, and research initiatives: JACC State-of-the-Art Review. J Am Coll Cardiol 2023;82:1264–79. 

Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2021;78:2218-61. 

 Subscribe to CardiaCast |  

Special Edition: PharmD Appreciation: “PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based solutions to everyday challenges. This series, published during American Pharmacists Month, celebrates our pharmacist CV Team members in an educational series with a specific PharmD focus. In this episode, Andrea Price, MS, AACC hosts Jessie Dunne, PharmD, BCCP, BCPC and Orly Vardeny, PharmD, MS, FAHA, FHFSA to discuss the most recent heart failure guidelines, expert consensus publication, and what these documents mean to a pharmacist working on a heart failure care team.   

Subscribe to CardiaCast  

“Women are Not Little Men” is a new podcast series within CardiaCast designed for cardiovascular health providers to increase awareness of sex-based differences in cardiovascular disease (CVD) and to improve the clinical care of women with CVD. “Women are Not Little Men” is hosted by Drs. Emily Lau and Niti Aggarwal, nationally renowned experts in women’s CVD and members of the American College of Cardiology CVD in Women Committee. In this episode, Drs. Annabelle Volgman and Kamala Tamirisa discuss sex differences in arrhythmias, including atrial fibrillation and ventricular tachyarrhythmias, as well as gender disparities related to medical and device therapies for arrhythmia treatment. 

 Suggested Materials:  

 Ehdaie A, Cingolani E, Shehata M, Wang X, Curtis AB, Chugh SS. Sex differences in cardiac arrhythmias: clinical and research implications. Circ Arrhythm Electrophysiol 2018;11:e005680.  

 Linde C, Bongiorni MG, Birgersdotter-Green U, et al. Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society. Europace 2018;20:1565-1565ao.  

 Amuthan R, Curtis A. Sex-specific considerations in drug and device therapy of cardiac arrhythmias: JACC Focus Seminar 6/7. J Am Coll Cardiol 2022:79;1519–29. 

 Subscribe to CardiaCast |  

In this episode, Erin Michos MD, FACC, and Alison Bailey MD, FACC discuss the CLEAR Outcomes primary prevention analysis focusing on bempedoic acid and its clinical implications. 

 This podcast is part of the Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape grant initiative. 

 Educational grant support is provided by Esperion. 

 Suggested Materials: 

Nissen SE, Menon V, Nicholls SJ, et al. Bempedoic acid for primary prevention of cardiovascular events in statin-intolerant patients. JAMA. 2023;330:131-140.  

 Subscribe to CardiaCast | More Information on Bempedoic Acid HERE 

“Women are Not Little Men” is a new podcast series within CardiaCast designed for cardiovascular health providers to increase awareness of sex-based differences in cardiovascular disease (CVD) and to improve the clinical care of women with CVD. “Women are Not Little Men” is hosted by Drs. Emily Lau and Niti Aggarwal, nationally renowned experts in women’s CVD and members of the American College of Cardiology CVD in Women Committee. In this episode, Drs. Chrisandra Shufelt and JoAnn Manson discuss up-to-date evidence on hormone therapy and CVD risk.  

Suggested Materials:  

 Cho L, Kaunitz AM, Faubion SS, et al. Rethinking menopausal hormone therapy: for whom, what, when, and how long? Circulation 2023;147:597-610.  

 Shifren JL, Crandall CJ, Manson JE. Menopausal hormone therapy. JAMA 2019;321:2458-9.  

 Subscribe to CardiaCast |  

In this episode, Drs. Shashank Sinha and Dr. Rosy Thachil launch a brand-new series, “Conversations with Critical Care Cardiologists” sponsored by ACC’s Critical Care Cardiology (CCC) Section. Listen to Drs. Sinha and Thachil as they interview leading luminaries in critical care cardiology, Drs. Robert Roswell and Michael Solomon, Chair and Chair-Elect, respectively, of the ACC’s Critical Care Cardiology Section Leadership Council. Enjoy a fun-filled, wide-ranging conversation, as they reflect on their personal and professional journey, discuss challenges in founding the inaugural CCC section, and articulate a bold new vision for this rapidly evolving field.

Subscribe to CardiaCast | Claim CME Credit